Literature DB >> 27354892

Cardiomyopathy in becker muscular dystrophy: Overview.

Rady Ho1, My-Le Nguyen1, Paul Mather1.   

Abstract

Becker muscular dystrophy (BMD) is an X-linked recessive disorder involving mutations of the dystrophin gene. Cardiac involvement in BMD has been described and cardiomyopathy represents the number one cause of death in these patients. In this paper, the pathophysiology, clinical evaluations and management of cardiomyopathy in patients with BMD will be discussed.

Entities:  

Keywords:  Becker muscular dystrophy; Cardiomyopathy; Dystrophin; X-linked recessive disorder

Year:  2016        PMID： 27354892      PMCID： PMC4919702          DOI： 10.4330/wjc.v8.i6.356

Source DB:  PubMed          Journal:  World J Cardiol


  34 in total

Review 1.  Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy.

Authors:  Ali Yilmaz; Udo Sechtem
Journal:  Heart       Date:  2012-03       Impact factor: 5.994

2.  Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Heart Lung       Date:  2005 Sep-Oct       Impact factor: 2.210

3.  Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Denis Duboc; Christophe Meune; Guy Lerebours; Jean-Yves Devaux; Guy Vaksmann; Henri-Marc Bécane
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Eteplirsen for the treatment of Duchenne muscular dystrophy.

Authors:  Jerry R Mendell; Louise R Rodino-Klapac; Zarife Sahenk; Kandice Roush; Loren Bird; Linda P Lowes; Lindsay Alfano; Ann Maria Gomez; Sarah Lewis; Janaiah Kota; Vinod Malik; Kim Shontz; Christopher M Walker; Kevin M Flanigan; Marco Corridore; John R Kean; Hugh D Allen; Chris Shilling; Kathleen R Melia; Peter Sazani; Jay B Saoud; Edward M Kaye
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

5.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.

Authors:  Subha V Raman; Kan N Hor; Wojciech Mazur; Nancy J Halnon; John T Kissel; Xin He; Tam Tran; Suzanne Smart; Beth McCarthy; Michael D Taylor; John L Jefferies; Jill A Rafael-Fortney; Jeovanna Lowe; Sharon L Roble; Linda H Cripe
Journal:  Lancet Neurol       Date:  2014-12-30       Impact factor: 44.182

6.  Subclinical cardiomyopathy in Becker muscular dystrophy.

Authors:  S E Steare; V Dubowitz; A Benatar
Journal:  Br Heart J       Date:  1992-09

7.  [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].

Authors:  K Toifl; E Presterl; W Graninger
Journal:  Wien Klin Wochenschr       Date:  1991       Impact factor: 1.704

8.  Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins.

Authors:  Eric K Johnson; Liwen Zhang; Marvin E Adams; Alistair Phillips; Michael A Freitas; Stanley C Froehner; Kari B Green-Church; Federica Montanaro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 9.  Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy.

Authors:  Tirsa L E van Westering; Corinne A Betts; Matthew J A Wood
Journal:  Molecules       Date:  2015-05-15       Impact factor: 4.411

10.  Cardiac involvement in Becker muscular dystrophy.

Authors:  P Melacini; M Fanin; G A Danieli; G Fasoli; C Villanova; C Angelini; L Vitiello; M Miorelli; G F Buja; M L Mostacciuolo
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094
View more
  9 in total

Review 1.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

Review 2.  Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases.

Authors:  Gaspar Del Rio-Pertuz; Cristina Morataya; Kanak Parmar; Sarah Dubay; Erwin Argueta-Sosa
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

3.  Cardiovascular progenitor cells and tissue plasticity are reduced in a myocardium affected by Becker muscular dystrophy.

Authors:  Martin Pesl; Sarka Jelinkova; Guido Caluori; Maria Holicka; Jan Krejci; Petr Nemec; Aneta Kohutova; Vita Zampachova; Petr Dvorak; Vladimir Rotrekl
Journal:  Orphanet J Rare Dis       Date:  2020-03-05       Impact factor: 4.123

Review 4.  The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.

Authors:  Mariana M Lamacie; Jodi Warman-Chardon; Andrew M Crean; Anca Florian; Karim Wahbi
Journal:  J Neuromuscul Dis       Date:  2019

5.  Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy.

Authors:  Sholeh Bazrafshan; Hani Kushlaf; Mashhood Kakroo; John Quinlan; Richard C Becker; Sakthivel Sadayappan
Journal:  Cells       Date:  2021-02-08       Impact factor: 6.600

6.  Late-Onset Dystrophinopathy.

Authors:  Ranjan K Singh
Journal:  Cureus       Date:  2021-12-20

Review 7.  Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart.

Authors:  Xaver Koenig; Janine Ebner; Karlheinz Hilber
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 6.208

8.  Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy.

Authors:  James D West; Cristi L Galindo; Kyungsoo Kim; John Jonghyun Shin; James B Atkinson; Ines Macias-Perez; Leo Pavliv; Bjorn C Knollmann; Jonathan H Soslow; Larry W Markham; Erica J Carrier
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501

9.  The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin.

Authors:  Yaohua Zhang; Yajuan Li; Qingsong Hu; Yutao Xi; Zhen Xing; Zhao Zhang; Lisa Huang; Jianbo Wu; Ke Liang; Tina K Nguyen; Sergey D Egranov; Chengcao Sun; Zilong Zhao; David H Hawke; Jin Li; Deqiang Sun; Jean J Kim; Ping Zhang; Jie Cheng; Abid Farida; Mien-Chie Hung; Leng Han; Radbod Darabi; Chunru Lin; Liuqing Yang
Journal:  Nat Cell Biol       Date:  2020-10-26       Impact factor: 28.213
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.